Literature DB >> 19410950

Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema.

Matthias Bolz1, Ursula Schmidt-Erfurth, Gabor Deak, Georgios Mylonas, Katharina Kriechbaum, Christoph Scholda.   

Abstract

PURPOSE: To analyze hyperreflective foci typically seen in diabetic macular edema (DME) in optical coherence tomography (OCT).
DESIGN: Prospective clinical trial. PARTICIPANTS: Twelve consecutive patients with treatment-naïve, clinically significant DME.
METHODS: During a same-day examination, a standardized visual acuity assessment (Early Treatment of Diabetic Retinopathy Study protocol), infrared fundus imaging, color fundus photography, and biomicroscopy were performed. Additionally, all patients were scanned using Stratus, Cirrus, and Spectralis OCT and results correlated. MAIN OUTCOME MEASURES: Morphologic changes secondary to DME.
RESULTS: In all eyes with DME, distinct hyperreflective foci distributed throughout all retinal layers were found in the OCT scans of all 3 OCT devices. These deposits could not be identified by infrared imaging, fundus photography, or biomicroscopy as long as they were not confluent. Accumulations of such foci at the border of the outer nuclear and in the outer plexiform layer were recognizable clinically as hard exudates showing the same hyperreflective features in OCT. The hyperreflectivity of these foci did not correspond with intraretinal hemorrhage, nor did the lesions cause the characteristic OCT laser beam scattering phenomena typically seen secondary to intraretinal bleedings or microaneurysms. Further, they were detected within the walls of intraretinal microaneurysms.
CONCLUSIONS: Well-demarcated, hyperreflective foci were identified in the retina of patients with DME. The deposits were located within walls of intraretinal microaneurysms and scattered throughout all retinal layers, forming confluent plaques in the outer plexiform layer. It is suggested that the foci represent extravasated lipoproteins and/or proteins being a very early subclinical barrier breakdown sign in DME.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19410950     DOI: 10.1016/j.ophtha.2008.12.039

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  121 in total

1.  Relationship between retinal morphological findings and visual function in age-related macular degeneration.

Authors:  Yumiko Akagi-Kurashige; Akitaka Tsujikawa; Akio Oishi; Sotaro Ooto; Kenji Yamashiro; Hiroshi Tamura; Isao Nakata; Naoko Ueda-Arakawa; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08       Impact factor: 3.117

2.  Macular morphologic findings on optical coherence tomography after microincision vitrectomy for proliferative diabetic retinopathy.

Authors:  Tomoaki Murakami; Akihito Uji; Ken Ogino; Noriyuki Unoki; Shin Yoshitake; Yoko Dodo; Takahiro Horii; Kazuaki Nishijima; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2015-05-09       Impact factor: 2.447

3.  Efficient method to suppress artifacts caused by tissue hyper-reflections in optical microangiography of retina in vivo.

Authors:  Yanping Huang; Qinqin Zhang; Ruikang K Wang
Journal:  Biomed Opt Express       Date:  2015-03-10       Impact factor: 3.732

4.  Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.

Authors:  Katja Hatz; Andreas Ebneter; Cengiz Tuerksever; Christian Pruente; Martin Zinkernagel
Journal:  Ophthalmologica       Date:  2018-02-02       Impact factor: 3.250

Review 5.  [Diagnosis, treatment and monitoring of diabetic eye control].

Authors:  Stephan Radda; Matthias Bolz; Stefan Egger; Vanessa Gasser-Steiner; Martina Kralinger; Stefan Mennel; Christoph Scholda; Ulrike Stolba; Andreas Wedrich; Katharina Krepler
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

Review 6.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

7.  Multimodal evaluation of macular function in age-related macular degeneration.

Authors:  Ken Ogino; Akitaka Tsujikawa; Kenji Yamashiro; Sotaro Ooto; Akio Oishi; Isao Nakata; Masahiro Miyake; Ayako Takahashi; Abdallah A Ellabban; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2013-12-12       Impact factor: 2.447

8.  [Diagnosis, therapy and follow up of diabetic eye disease].

Authors:  Michael Stur; Stefan Egger; Anton Haas; Gerhard Kieselbach; Stefan Mennel; Reinhard Michl; Michael Roden; Ulrike Stolba; Andreas Wedrich
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

9.  Visualizing Structure and Vascular Interactions: Macular Nonperfusion in Three Capillary Plexuses.

Authors:  Justin J Park; Christopher S Chung; Amani A Fawzi
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2018-11-01       Impact factor: 1.300

10.  Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Authors:  Philip Hykin; A Toby Prevost; Sobha Sivaprasad; Joana C Vasconcelos; Caroline Murphy; Joanna Kelly; Jayashree Ramu; Abualbishr Alshreef; Laura Flight; Rebekah Pennington; Barry Hounsome; Ellen Lever; Andrew Metry; Edith Poku; Yit Yang; Simon P Harding; Andrew Lotery; Usha Chakravarthy; John Brazier
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.